1-3 of 3
Alex Baturevych
Close
Sort by
Journal Articles

Lenalidomide Enhances Anti-BCMA Chimeric Antigen Receptor T Cell Function Against Multiple Myeloma

Melissa Works, PhD, Neha Soni, MS, Collin Hauskins, Catherine Sierra, BS, Alex Baturevych, BS, Jon Jones, BS, Wendy Curtis, BS, Timothy Johnstone, PhD, David Kugler, PhD, Yue Jiang, PhD, Ron Hause, PhD, Blythe Duke Sather, PhD, Ruth Salmon, PhD, Michael Ports, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1794.
https://doi.org/10.1182/blood.V130.Suppl_1.1794.1794
Published: 2017
Journal Articles

Development of JCARH125: Optimization of a Fully Human Anti-Bcma CAR for Use in the Treatment of Multiple Myeloma

Kim Harrington, BS, Rebecca Wu, BS, Collin Hauskins, BS, Rupesh Amin, PhD, Thomas Long, PhD, Aye Chen, BA, Ayu Rahardjo, BS, Casey Thayer, BS, Garnet Navvaro, BS, Madelyn Myers, MS, Jon Jones, BS, Alex Baturevych, BS, Stan Morkowski, PhD, Ruth Salmon, PhD, Christopher J Bond, PhD, Mette Staehr, PhD, Terence J Purdon, MS, Reed Masakayan, MS, Cheng Liu, PhD, Hong Liu, MD PhD, Yiyang Xu, PhD, Pei Wang, PhD, Margot Pont, PhD, Damian J. Green, MD, Renier J. Brentjens, MD PhD, Eric L Smith, MDPhD, Blythe Duke Sather, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1813.
https://doi.org/10.1182/blood.V130.Suppl_1.1813.1813
Published: 2017
Journal Articles

Preclinical Analyses Support Clinical Investigation of Combined Anti-CD19 CAR-T Cell, JCAR017 with Ibrutinib for the Treatment of Chronic Lymphocytic Leukemia

Jim Qin, Alex Baturevych, Sherri Mudri, Ruth Salmon, PhD, Michael Ports, PhD
Journal: Blood
Blood (2016) 128 (22): 3231.
https://doi.org/10.1182/blood.V128.22.3231.3231
Published: 2016